UCLA researcher found guilty of misconduct

Scientist sanctioned for faking data and stealing money intended for subjects

Written byBob Grant
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
A researcher at the University of California, Los Angeles' Semel Institute for Neurosciences and Human Behavior faked interviews, tampered with data and urine samples, and stole money intended for study, according to a notice published this week in the Federal Register.According to the notice, James Lieber, "knowingly and intentionally falsified" data over six months during a 2005 study, which was funded in part with National Institutes of Health (NIH) grants.The study tracked female opiate addicts who had visited methadone clinics in Southern California during the late 1970s.Lieber, 46, fabricated 20 face-to-face interviews with study subjects, and provided false urine samples for those subjects, according to the U.S. Department of Health and Human Services' Office of Research Integrity (ORI), which investigated the events. Lieber, who was hired at UCLA in June 2005, also stole $5,180 in cash that was supposed to go to the study's participants as incentives and to cover travel expenses.John Dahlberg, director of ORI's Division of Investigative Oversight, told The Scientist that Lieber's misconduct was brought to light on January 12, 2006, when he was reported to the University of California Police Department for stealing money intended for study participants and that "there were concerns that he had walked off with a laptop computer and other equipment." Later in the year, Dahlberg said, it became clear that Lieber had faked interviews because UCLA sent Christmas cards out to study participants that were returned as undeliverable. Five of the people Lieber claimed to have interviewed were dead at the time he claimed to have spoken with them.Dahlberg said that the ORI learned of the case that June. "It took a number of months before we were able to bring it to a point to where we could deal with it," he said. "It was handled awkwardly by UCLA." Dahlberg said that action in the case was delayed by UCLA's policy of dealing with instances of research misconduct at the level of dean, who initially decided that the case did not warrant an investigation. Eventually, the case was reconsidered and an internal research integrity officer alerted ORI in June. "There's no question it was a very serious matter," Dahleberg told The Scientist. According to Dahlberg, Lieber was uncooperative with investigators. "He, in fact, sort of disappeared" after the UC police were alerted in January. "We don't know where he is," said Dahlberg."The scope of what he did was probably larger than what UCLA was able to prove," said Dahlberg. "The concern is that almost everything [Lieber] had to do" with the study subjects he was assigned to interview was "unreliable."In a statement e-mailed to The Scientist, vice chancellor of research at UCLA Roberto Peccei wrote that he learned of the misconduct in early 2006, convened a panel to conduct an internal review, and forwarded the results of that review to the ORI. Peccei also wrote that Lieber is no longer a UCLA employee.Lieber could not be reached for comment.The UCLA statement also says that, "none of the compromised or false data was published," and that the study continues with that data having been purged from the database.The head researcher on the study was Christine Grella, a psychologist at UCLA's Integrated Substance Abuse Programs. Grille's research addresses mental health issues and substance abuse. Her most recent paper, published in July, described a study of the treatment needs of female prison inmates with substance abuse problems. Grella could not be reached for comment.According to the notice in the Federal Register, ORI has implemented sanctions against Lieber, including a three year ban on working with any agency of the U.S. government and a prohibition on functioning in any advisory role to the U.S. Public Health Service.Bob Grant mail@the-scientist.comLinks within this article:Semel Institute for Neurosciences and Human Behavior http://www.npi.ucla.eduFederal Register Notice http://a257.g.akamaitech.netChristine Grella http://www.uclaisap.org/profiles/grella.htmlCE Gella et al., "Treatment needs and completion of community-based aftercare among substance-abusing women offenders," Women's Health Issues, July -August 2007. http://www.the-scientist.com/pubmed/17544296
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform